Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Vanguard Russell 1000 ETF
VONE
$8.72B
| $1.21M | ﹤0.01% |
6,200
+2,300
| +59% | +$466K |
|
2177
Riverview Bancorp
RVSB
$106M
| $1.2M | ﹤0.01% |
216,607
-6,197
| -3% | -$35K |
|
2178
Citizens & Northern Corp
CZNC
$466M
| $1.2M | ﹤0.01% |
68,541
-3,500
| -5% | -$67.7K |
|
2179
CytomX Therapeutics
CTMX
$732M
| $1.2M | ﹤0.01% |
930,100
-192,300
| -17% | -$303K |
|
2180
Dorman Products
DORM
$4.05B
| $1.2M | ﹤0.01% |
15,800
-7,800
| -33% | -$634K |
|
2181
Envela
ELA
$416M
| $1.2M | ﹤0.01% |
252,430
-7,574
| -3% | -$45.7K |
|
2182
Vera Therapeutics
VERA
$2.28B
| $1.2M | ﹤0.01% |
+87,200
| New | +$1.5M |
|
|
GBIO
2183
DELISTED
Generation Bio
GBIO
| $1.19M | ﹤0.01% |
31,480
+670
| +2% | +$31.7K |
|
|
SEM
2184
DELISTED
Select Medical
SEM
| $1.19M | ﹤0.01% |
+87,603
| New | +$1.35M |
|
|
WHWK
2185
Whitehawk Therapeutics
WHWK
$254M
| $1.19M | ﹤0.01% |
245,922
+41,800
| +20% | +$243K |
|
2186
Taylor Devices
TAYD
$178M
| $1.19M | ﹤0.01% |
55,762
+8,100
| +17% | +$182K |
|
|
TRT
2187
Trio-Tech International
TRT
$116M
| $1.19M | ﹤0.01% |
339,426
-26,300
| -7% | -$79.9K |
|
2188
Huntington Ingalls Industries
HII
$12.9B
| $1.19M | ﹤0.01% |
+5,800
| New | +$1.28M |
|
|
HIMX
2189
Himax Technologies
HIMX
$2.66B
| $1.18M | ﹤0.01% |
202,000
-23,900
| -11% | -$153K |
|
2190
Movado Group
MOV
$803M
| $1.18M | ﹤0.01% |
43,100
-6,200
| -13% | -$169K |
|
|
MRSN
2191
DELISTED
Mersana Therapeutics
MRSN
| $1.18M | ﹤0.01% |
37,037
-4,880
| -12% | -$232K |
|
2192
Embotelladora Andina Series A
AKO.A
$3.75B
| $1.17M | ﹤0.01% |
101,400
-1,000
| -1% | -$12.3K |
|
2193
Transportadora de Gas del Sur
TGS
$4.23B
| $1.17M | ﹤0.01% |
115,000
+24,639
| +27% | +$302K |
|
2194
AdvanSix
ASIX
$460M
| $1.17M | ﹤0.01% |
37,600
-7,400
| -16% | -$257K |
|
2195
Taboola.com
TBLA
$1.09B
| $1.17M | ﹤0.01% |
308,400
-722,499
| -70% | -$2.54M |
|
2196
Graham Holdings Company
GHC
$5.04B
| $1.17M | ﹤0.01% |
2,000
-4,200
| -68% | -$2.43M |
|
2197
Navient
NAVI
$860M
| $1.16M | ﹤0.01% |
67,600
-299,800
| -82% | -$5.4M |
|
|
GNTY
2198
DELISTED
Guaranty Bancshares
GNTY
| $1.16M | ﹤0.01% |
40,529
-500
| -1% | -$14.7K |
|
2199
Advantage Solutions
ADV
$420M
| $1.16M | ﹤0.01% |
16,352
+8,481
| +108% | +$563K |
|
2200
Identive
INVE
$64.1M
| $1.16M | ﹤0.01% |
137,482
-32,800
| -19% | -$273K |
|
Similar funds
Jim Simons's Q3 2023 Portfolio in Review
As of Q3 2023, Jim Simons held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in D.R. Horton worth $125M.
- Jim Simons's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Jim Simons added most to Netflix in Q3 2023, an estimated $385M increase.
- Jim Simons's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Jim Simons fully exited Chevron in Q3 2023, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Jim Simons opened 464 new positions and closed 713 in Q3 2023.
- Jim Simons's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.